Quantcast

Golden State Today

Monday, June 24, 2024

After California copay accumulator ban bill stalls in committee, its supporters hope to see it passed in next annual session

Webp lynnekinst

Lynne Kinst, Executive Director of Hemophilia Council of California | hemophiliaca.org

Lynne Kinst, Executive Director of Hemophilia Council of California | hemophiliaca.org

An official from the Hemophilia Council of California advocates that state lawmakers should approve a future ban on a program used by some health insurers in the United States, which does not count copay assistance payments toward a patient’s deductible or out-of-pocket maximum.

Lynne Kinst is the Executive Director of the Hemophilia Council of California, one of five organizations which had co-sponsored Assembly Bill 2180 – legislation which would have served to ban the above patient payment framework, known as copay accumulators.

Despite a plethora of external support from health care-focused advocacy organizations and health care providers, the bill did not emerge from its committee process.

Kinst outlined why the Hemophilia Council is opposed to the practice of copay accumulators.

“We believe California should ban copay accumulators because these policies prevent financial assistance from counting towards a patient’s deductible and out-of-pocket maximum. This increases the financial burden on patients, who already face high costs, as they must pay more out-of-pocket before reaching their deductible, leading to potential treatment delays and decreased adherence to their necessary medical needs. And the patients who use financial assistance programs need them – 69% of patients who receive assistance earn less than $40,000 per year,” Kinst told Golden State Today.

This practice further levies steep financial burdens and a detriment to the quality of life for hemophilia patients, Kinst explained.

“Copay accumulator policies significantly increase the financial strain associated with managing a complex condition. Hemophilia treatments are costly, and without the support of financial assistance counting toward out-of-pocket limits, patients face prohibitive expenses. This often results in skipped or reduced treatment, which negatively affects their health and quality of life,” said Kinst.  

Though AB2180 did not make it out of committee, Kinst said its supporters remain determined to get the legislation passed in the next annual session.

“Assembly Bill 2180 garnered significant support from patient advocacy groups, providers and health care organizations, but unfortunately died in [the] Committee [on Appropriations]. We are still committed to seeing this passed in California, though, and will try again next year,” said Kinst.  

While some health insurers say copay accumulator bans would result in higher insurance premiums, a May 2023 analysis by The AIDS Institute found “no evidence that enacting a copay accumulator adjustment ban has a meaningful impact on average premiums.” That analysis looked at 16 states that banned CAAPS between 2019 and 2022.

Julie Gull Sheffield, who works with the group Patients Come First said that copay assistance is a “critical resource” to provide patients the “assistance they need to access medications,” but that “often copay accumulators are used to block those discounts from helping patients by not allowing it to count toward a patient’s deductible and out-of-pocket maximums.”

Alongside the Hemophilia Council of California, the ALS Association, California Rheumatology Alliance, Cystic Fibrosis Research Institute and the Sickle Cell Disease Foundation had co-signed AB2180, in the hopes that patients who may otherwise face severe financial burdens under a copay accumulator, would have a reprieve.

California currently does not require insurers to count all payments made by patients, even those from patient assistance programs, toward the patient’s out-of-pocket maximum.

Currently, 21 states, Washington, D.C. and Puerto Rico have passed laws mandating that health insurers count the value of copay assistance towards a patient’s cost-sharing responsibilities, including Arizona, Arkansas, Colorado, Connecticut, Delaware, Georgia, Illinois, Kentucky, Louisiana, Maine, New Mexico, New York, North Carolina, Oklahoma, Oregon, Tennessee, Texas, Vermont, Virginia, Washington and West Virginia.

Which states ban copay accumulators?

Source: National Conference of State Legislatures

State Name

Ban on Copay Accumulators?

Alabama

No

Alaska

No

Arizona

Yes

Arkansas

Yes

California

No

Colorado

Yes

Connecticut

Yes

Delaware

Yes

District of Columbia

Yes

Florida

No

Georgia

Yes

Hawaii

No

Idaho

No

Illinois

Yes

Indiana

No

Iowa

No

Kansas

No

Kentucky

Yes

Louisiana

Yes

Maine

Yes

Maryland

No

Massachusetts

No

Michigan

No

Minnesota

No

Mississippi

No

Missouri

No

Montana

No

Nebraska

No

Nevada

No

New Hampshire

No

New Jersey

No

New Mexico

Yes

New York

Yes

North Carolina

Yes

North Dakota

No

Ohio

No

Oklahoma

Yes

Oregon

Yes

Pennsylvania

No

Rhode Island

No

South Carolina

No

South Dakota

No

Tennessee

Yes

Texas

Yes

Utah

No

Vermont

Yes

Virginia

Yes

Washington

Yes

West Virginia

Yes

Wisconsin

No

Wyoming

No

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS